CGH

Researchers who set out to compare the ability of SNP and comparative genomic hybridization microarray platforms to detect copy number variation in autusm spectrum disorder managed to identify 16 genes that hadn't been associated with ASD before.

CHICAGO — Cancer Genetics will later this year expand its menu of array-based tests to include assays for informing treatment of patients with diffuse large B-cell lymphoma and renal cell carcinoma.

By Justin Petrone
ArrayGenomics recently began selling a comparative genomic hybridization array that it claims can be used to diagnose, grade, and stage bladder cancer based on DNA extracted from urine.

This article has been updated to include comments from Roche.
By Justin Petrone

This story was originally posted on Nov. 17.
By Justin Petrone

By Justin Petrone
Growing demand for arrays designed to detect tumor copy-number changes is enticing more chip manufacturers to offer tools tailor-made for cancer research.

Roche NimbleGen has certified the University of Iowa's Roy J. Carver Center for Genomics to offer microarray services on its platform, Roche said last week.

The Madrid-based genetic diagnostics center, which is authorized by Madrid's health department and is accredited by the Spanish Association of Human Genetics, becomes Agilent's first certified service provider in the country.

Pages

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.